Emerging Opportunities in Alzheimer’s Disease
A Market on the Brink of Transformation
[bitsontherun Y2l2PwrG-UkntMX1A]
Perhaps more than any other category, the Alzheimer’s Disease market is on the cusp of a game-changing transition. Fueled by an aging boomer population that is on deck to become an exploding Alzheimer’s patient population, the following changes are just over the horizon and poised to radically transform this market:
- The development of disease-modifying agents that treat the cause rather than the symptoms of Alzheimer’s
- A shift, triggered by the advent of biologics, from primary care physicians to specialists, such as neurologists and psychiatrists, as the dominant treaters of Alzheimer’s
- The impact of successful R&D efforts and the shift to specialists on the cost of care and third-party payors such as Medicare Part D
